Aimmune Therapeutics, Inc. 4
4 · Aimmune Therapeutics, Inc. · Filed May 27, 2016
Insider Transaction Report
Form 4
Seltzer Stacey Denenberg
Director
Transactions
- Award
Stock Option (right to buy)
2016-05-25+19,755→ 19,755 totalExercise: $15.40Exp: 2026-05-25→ Common Stock (19,755 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2017 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.